Loading
CTS Corp: what insiders have been doing
CTS Corp is a Industry company. Its directors and officers file their transactions with SEC (Form 4). 11 insiders have disclosed 26 filings since 18 October 2025.
Only sales appear on the open market, 4 sales in all totalling €8.4M, filed by 2 insiders. One trade stands out by size: a sale of €3.4M from O'Sullivan Kieran M, disclosed on 3 June 2026, or 0.22% of market capitalisation.
For context, the typical company on the same exchange (median of 5,810 companies) published 19 filings over the same period, against 26 filings here. The full history, which starts in 2021, counts no purchases against 24 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 541.3 m USD and net income of 65.3 m USD, with a dividend of 0.16 USD per share.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Elsewhere in the same sector, our signals recently picked up insider purchases at Tennant Co and Butler National Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
122
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€15M
24 ops. · all time
Who traded when
BuySaleKieran M. O'Sullivan6 sales
Ashish Agrawal1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 6,836 of 24,148 companies
62.4
score / 100
Value56
Quality69
FCF yld5.5%
Earn yld4.1%
EV/EBITDA13.6x
ROE12%
Gross mgn38%
Net mgn12%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$55.29
Analyst consensus
3 analysts1.50/5
US$65.00Target US$70.67(+28%)US$80.00
Income statement
RevenueUS$541.3M
Gross profitUS$208M38% margin
EBITDAUS$122.6M23% margin
Net incomeUS$65.3M12.4% margin
Valuation
PER (trailing)23.1x
PER (forward)19.3x
P/Book2.8x
Beta0.99
Balance sheet & cash
Market capUS$1.6B
Total debtUS$82.8M
Free Cash FlowUS$86.4M
Debt / Equity16%
Profitability & ownership
ROE12.4%
ROA7.3%
% insiders2.1%
% institutions100.0%
Last declaration on 30 July 2026
Declarations122 total
531 shares@ US$61.530.0019% mcap13.9% of flowCommon StockSEC:0000026058-26-000030:0
14,253 shares@ US$60.340.050% mcap79.4% of flowCommon StockSEC:0000026058-26-000029:0
46,955 shares@ US$63.31110.17% mcap17.1% of flowCommon StockSEC:0000026058-26-000028:0
60,388 shares@ US$66.26270.22% mcap23.1% of flowCommon StockSEC:0000026058-26-000028:1
22,657 shares@ US$66.67080.084% mcap8.7% of flowCommon StockSEC:0000026058-26-000028:2
1,253 shares0Common StockSEC:0000026058-26-000027:0
757 shares0Common StockSEC:0000026058-26-000027:1
4,310 shares@ US$52.945.6% of flowCommon StockSEC:0000026058-26-000020:0
16,873 shares@ US$52.945.1% of flowCommon StockSEC:0000026058-26-000019:0
3,693 shares@ US$57.1586.1% of flowCommon StockSEC:0000026058-26-000017:0
3,500 shares@ US$57.1517.8% of flowCommon StockSEC:0000026058-26-000013:0
24,596 shares@ US$56.927.9% of flowCommon StockSEC:0000026058-26-000018:0
6,002 shares@ US$57.158.3% of flowCommon StockSEC:0000026058-26-000012:0
125 shares@ US$54.190.0004% mcap0.6% of flowCommon StockSEC:0000026058-26-000011:0
827 shares@ US$55.581.1% of flowCommon StockSEC:0000026058-26-000009:0
3,237 shares@ US$55.581.0% of flowCommon StockSEC:0000026058-26-000010:0
289 shares@ US$54.191.4% of flowCommon StockSEC:0000026058-26-000006:0
3,680 shares@ US$55.781.2% of flowCommon StockSEC:0000026058-26-000008:0
931 shares@ US$54.191.2% of flowCommon StockSEC:0000026058-26-000007:0
25,000 shares@ US$53.0032.3% of flowCommon StockSEC:0000026058-26-000003:0
3,500 shares0Common StockSEC:0000026058-25-000024:0
3,500 shares0Common StockSEC:0000026058-25-000025:0
3,500 shares0Common StockSEC:0000026058-25-000023:0
3,500 shares0Common StockSEC:0000026058-25-000021:0
3,500 shares0Common StockSEC:0000026058-25-000020:0
25 of 122 declarations
About CTS Corp
CTS Corporation is a US-listed industrial technology company traded on the NYSE (United States). The company focuses on engineered electronic solutions built around its three-part portfolio concept: “Sense, Connect and Move.” In practical terms, CTS designs and manufactures sensors, connectivity components, and actuators used in demanding applications across aerospace and defense, industrial, medical, transportation, and, to a lesser extent, other original equipment markets. Its customer base is primarily composed of OEMs, tier-one suppliers, and certain U.S. government-related end users.
CTS traces its origins back to 1896, when it was established as a provider of high-quality telephone products. The business was later incorporated in Indiana in February 1929. That heritage matters because it highlights the company’s long evolution from a traditional component maker into a global supplier of highly engineered electronic devices. Today, CTS is headquartered in Lisle, Illinois, in the United States, which places it at the center of a diversified Midwestern industrial ecosystem.
Read moreShow less
From a business-line perspective, CTS is differentiated less by commodity products and more by application-specific engineering. Its sensor portfolio is designed to capture and transmit critical information in complex systems. Its connectivity components help systems operate in sync and communicate reliably. Its motion and actuator solutions are built to deliver controlled mechanical movement in environments where precision and durability are essential. Historically, CTS also served markets with switches, potentiometers, and piezoelectric materials and substrates, but the company’s current strategy is more focused on higher-value, technically demanding end markets.
CTS’ competitive position is driven by application engineering, long-standing customer relationships, and the ability to win programs that can generate recurring revenue over multiple product cycles. The company maintains an international commercial footprint with sales offices in China, the Czech Republic, Denmark, Germany, Japan, Singapore, Taiwan, and the United States. That global presence supports diversified demand, but it also leaves CTS exposed to end-market cyclicality, especially in transportation.
Recent developments have reinforced the company’s diversification strategy. CTS has been increasing exposure to medical, industrial, and aerospace and defense end markets, which now account for more than half of revenue. Its 2024 annual results showed lower consolidated sales, mainly due to weaker transportation volumes, but also reflected continued profitability improvement and solid cash generation. In 2025, CTS reported revenue growth led by diversified markets and highlighted the contribution from SyQwest, an acquisition intended to expand its defense capabilities. For investors, CTS offers a relatively specialized industrial profile, with the NYSE listing in the United States, a long operating history, and a strategic emphasis on innovation, end-market diversification, and engineered product content.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
